Who owns IGC Pharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IGC from SEC Form 13F filings across 36 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 36 institutions disclosed 5.2M shares of IGC Pharma, Inc. worth $1.4M — about 5.2% of shares outstanding; the largest disclosed holder is GEODE CAPITAL MANAGEMENT, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
36
13F holders
$1.4M
value, 2026 filers
5.2%
of shares outstanding (5.2M sh)
7
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IGC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 879,394 | $239,229 | 0.0% | 0.9% | -15.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 814,914 | $221,657 | 0.0% | 0.8% | +13.4% |
| 3 | BlackRock, Inc. | 703,798 | $191,433 | 0.0% | 0.7% | 0.0% |
| 4 | AdvisorShares Investments LLCNEW | 678,480 | $184,547 | 0.0% | 0.7% | new |
| 5 | CITADEL ADVISORS LLCNEW | 437,317 | $118,950 | 0.0% | 0.4% | new |
| 6 | VANGUARD FIDUCIARY TRUST CO | 419,413 | $114,080 | 0.0% | 0.4% | +0.8% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 286,608 | $77,957 | 0.0% | 0.3% | -40.8% |
| 8 | STATE STREET CORP | 200,799 | $54,617 | 0.0% | 0.2% | 0.0% |
| 9 | NORTHERN TRUST CORP | 170,274 | $46,315 | 0.0% | 0.2% | +50.1% |
| 10 | LAWOOD & CO | 75,000 | $20,400 | 0.0% | 0.1% | 0.0% |
| 11 | GOLDMAN SACHS GROUP INC | 65,541 | $17,827 | 0.0% | 0.1% | 0.0% |
| 12 | JANE STREET GROUP, LLCNEW | 62,610 | $17,030 | 0.0% | 0.1% | new |
| 13 | DEARBORN PARTNERS LLC | 59,401 | $15,622 | 0.0% | 0.1% | 0.0% |
| 14 | TRUIST FINANCIAL CORP | 48,667 | $13,237 | 0.0% | 0% | +32.7% |
| 15 | CITIGROUP INCNEW | 46,043 | $12,524 | 0.0% | 0% | new |
| 16 | Fisher Asset Management, LLC | 43,400 | $11,804 | 0.0% | 0% | 0.0% |
| 17 | XTX Topco Ltd | 39,378 | $10,711 | 0.0% | 0% | -22.3% |
| 18 | MORGAN STANLEY | 35,198 | $9,574 | 0.0% | 0% | +0.2% |
| 19 | COMMONWEALTH EQUITY SERVICES, LLC | 33,348 | $9,070 | 0.0% | 0% | -1.5% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,882 | $7,856 | 0.0% | 0% | -76.4% |
| 21 | Tower Research Capital LLC (TRC) | 27,607 | $7,509 | 0.0% | 0% | +31.2% |
| 22 | Vanguard Global Advisers, LLC | 14,944 | $4,065 | 0.0% | 0% | 0.0% |
| 23 | Wealthcare Advisory Partners LLC | 10,000 | $2,720 | 0.0% | 0% | 0.0% |
| 24 | Burnham & Co LLCNEW | 5,000 | $1,360 | 0.0% | 0% | new |
| 25 | Geneos Wealth Management Inc. | 3,000 | $810 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.